From BiomedGT
Relation between an independent continuant and a role.
e.g., X (molecular entity) has_role Y (role), i.e, X fills the role of Y
If C is an independent continuant and C1 a role continuant class, then C has_role R1 means that every instance of C fills some instances of role C1 everytime the role is realized in a particular context.
[source]: OBO Relation Ontology (release version 0.99, date 07:14:2006
Pages using the property “NPO has role(has role)”
Showing 22 pages using this property.
N | |
|---|
| Category:NPO Bleomycin(NPO 839) + | NPO Drug Directed Against Tumor DNA(NPO 188) +, NPO Antineoplastic Antibiotic(NPO 737) +, NPO Antineoplastic Alkylating Agent(NPO 235) +, … |
| Category:NPO Carboplatin(NPO 603) + | NPO Anticancer Drug That Induces Breakage Of DNA Helix(NPO 961) +, NPO DNA Crosslinking Agent(NPO 620) + |
| Category:NPO Cetuximab(NPO 577) + | NPO Drug Directed Against Extracellular Domain Of Membrane Receptor(NPO 523) + |
| Category:NPO Chlorambucil(NPO 346) + | NPO Anticancer Drug That Induces Breakage Of DNA Helix(NPO 961) +, NPO Antineoplastic Alkylating Agent(NPO 235) + |
| Category:NPO Cisplatin(NPO 608) + | NPO Anticancer Drug That Induces Breakage Of DNA Helix(NPO 961) +, NPO DNA Crosslinking Agent(NPO 620) + |
| Category:NPO Cyclophosphamide(NPO 890) + | NPO Anticancer Drug That Induces Breakage Of DNA Helix(NPO 961) +, NPO Antineoplastic Alkylating Agent(NPO 235) + |
| Category:NPO Doxorubicin(NPO 788) + | NPO DNA RNA Transcription Regulator(NPO 327) +, NPO Topoisomerase II Inhibitor(NPO 784) +, NPO Antineoplastic Antibiotic(NPO 737) +, … |
| Category:NPO Etoposide(NPO 168) + | NPO Topoisomerase II Inhibitor(NPO 784) + |
| Category:NPO Five Fluorouracil(NPO 365) + | NPO Thymidylate Synthase Inhibitor(NPO 435) +, NPO Antineoplastic Antimetabolite(NPO 487) +, NPO Anticancer Drug That Inhibits Protein Activity Related To DNA Synthesis(NPO 294) + |
| Category:NPO Fluorescein Isothiocyanate(NPO 134) + | NPO Fluorochrome(NPO 643) + |
| Category:NPO Gadolinium(NPO 380) + | NPO MRI Contrast Agent(NPO 581) + |
| Category:NPO Gefitinib(NPO 123) + | NPO Drug Directed Against Intracellular Domain Of Membrane Receptor(NPO 161) +, NPO Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor(NPO 409) + |
| Category:NPO Idarubicin(NPO 817) + | NPO DNA RNA Transcription Regulator(NPO 327) +, NPO Topoisomerase II Inhibitor(NPO 784) +, NPO Antineoplastic Antibiotic(NPO 737) +, … |
| Category:NPO Melphalan(NPO 874) + | NPO Anticancer Drug That Induces Breakage Of DNA Helix(NPO 961) +, NPO Antineoplastic Alkylating Agent(NPO 235) + |
| Category:NPO Methotrexate(NPO 741) + | NPO Folate Antagonist(NPO 460) +, NPO Dihydrofolate Reductase Inhibitor(NPO 876) + |
| Category:NPO Mitomycin(NPO 352) + | NPO Antineoplastic Antibiotic(NPO 737) +, NPO Antineoplastic Alkylating Agent(NPO 235) + |
| Category:NPO Mitoxantrone(NPO 597) + | NPO Topoisomerase II Inhibitor(NPO 784) +, NPO Antineoplastic Antibiotic(NPO 737) +, NPO Anticancer Drug That Inhibits Protein Activity Related To DNA Synthesis(NPO 294) + |
| Category:NPO Oxaliplatin(NPO 749) + | NPO Anticancer Drug That Induces Breakage Of DNA Helix(NPO 961) +, NPO DNA Crosslinking Agent(NPO 620) + |
| Category:NPO Paclitaxel(NPO 860) + | NPO Taxane Pocket Binding Agent(NPO 556) +, NPO Drug Directed Against Protein In Cytoplasm(NPO 496) + |
| Category:NPO Tamoxifen(NPO 254) + | NPO Selective Estrogen Receptor Modulator(NPO 130) +, NPO Anticancer Drug That Modifies Expression Of Specific Genes(NPO 437) + |
| Category:NPO Thalidomide(NPO 434) + | NPO Anticancer Drug Directed Against Endothelial Growth Factor Receptor(NPO 562) +, NPO Angiogenesis Inhibitor(NPO 595) + |
| Category:NPO Topotecan(NPO 645) + | NPO Topoisomerase I Inhibitor(NPO 864) + |
